News & Analysis on Clinical Trial Services & Contract Research And Development
BD Biosciences has acquired Atto Bioscience in a deal worth $25 million (€20m), allowing it to enter the emerging high content cell analysis market and enhancing its presence in the pharmaceutical and biotechnology sectors.
Growing demand for natural colours, excipients and probiotic cultures lifted third quarter sales at Danish ingredients firm Chr Hansen.
A collaboration between De Novo Pharmaceuticals and Peakdale Molecular of the UK has led to the launch of a library of drug-like compounds that interact with G protein-coupled receptors, a fertile new source of drug targets.
US company Sensitech has bought a Danish firm that shores up its position in temperature and humidity monitoring of supply chains and expands its presence into the European market.
Although Europe is a world leader in chemical production, holding 28 per cent of the world market, its proportion of global trade has dropped by 4 per cent over the past decade. The time has come to take action, according to two industry bodies.
The results of a new clinical trial provide evidence that Durect's Oradur delivery technology can reduce the risk of misuse or abuse of narcotic painkillers.
Sun Pharma of India has announced plans to buy an ailing cephalosporin bulk active company, Phlox Pharma, to gain access to an internationally approved generic active pharmaceutical ingredient.
The discovery of the three-dimensional structure of the anthrax toxin as it binds to and enters human cells could lead to both a treatment for the disease and a way to harness its effects in cancer therapy, according to a report in the journal Nature.